Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.

Altogether 117 patients with advanced breast cancer were treated with either tamoxifen 10 mg by mouth twice daily or aminoglutethimide 250 mg by mouth four times daily with hydrocortisone 20 mg twice daily in a randomised cross-over trial in which patients who failed to respond to the first treatmen...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Smith, I E, Harris, A L, Morgan, M, Ford, H T, Gazet, J C, Harmer, C L, White, H, Parsons, C A, Villardo, A, Walsh, G, McKinna, J A
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 1981
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC1507612/
https://ncbi.nlm.nih.gov/pubmed/6797571
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg